SCHEMBL6651884

SCHEMBL6651884

CCOC(=O)C(C)(C)Oc1ccc2[nH]c(C)c(C(=O)OCc3ccccc3)c2c1.Cc1[nH]c2ccc(O)cc2c1C(=O)OCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.60
ALOX5 P09917 12/20 0.54
MAPT P10636 3/20 0.53
KMT2A Q03164 2/20 0.53
KDM4E B2RXH2 2/20 0.53
LMNA P02545 2/20 0.53
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
HPGD P15428 1/20 0.53
MAPK10 P53779 1/20 0.53
HSD17B10 Q99714 1/20 0.53
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
GABRA1 P14867 1/20 0.44
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
GABRA2 P47869 1/20 0.44
PKM P14618 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318217 0.96 GAA (0.53) GAAALOX5MAPTKMT2AKDM4E
SCHEMBL6658684 0.94 GAA (0.50) GAAALOX5MAPTKMT2AKDM4E
SCHEMBL6314420 0.87 GAA (0.50) GAAALOX5MAPTKMT2AKDM4E
SCHEMBL6315808 0.85 GAA (0.74) GAAALOX5MAPTKMT2AKDM4E
SCHEMBL6314929 0.84 GAA (0.47) GAAALOX5MAPTKMT2AKDM4E
SCHEMBL6656803 0.80 GAA (0.57) GAAALOX5MAPTKMT2AKDM4E
SCHEMBL6656526 0.79 GAA (0.56) GAAALOX5MAPTKMT2AKDM4E
SCHEMBL13309192 0.79 GABRA1 (0.67) GAAALOX5MAPTKMT2AKDM4E
SCHEMBL7827626 0.78 GAA (0.53) GAAALOX5MAPTKMT2AKDM4E
SCHEMBL6314661 0.77 GAA (0.50) GAAALOX5MAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377549-A1 FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR Millennium Pharmaceuticals, Inc. (US) 2004-01-07 EP disclosed
WO-2002072549-A1 FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-09-19 WO disclosed